bluuebunny/crossref_metadata_2025 huggingface dataset:
Figure S2 from A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
Authors: Chan Wing Keung , Kang Siwen , Youssef Youssef , Glankler Erin N. , Barrett Emma R. , Carter Alex M. , Ahmed Elshafa H. , Prasad Aman , Chen Luxi , Zhang Jianying , Benson Don M. , Caligiuri Michael A. , Yu Jianhua
Published: April 2023

Gating strategy for identifying CS1(+) subset in the CD38(+)CD138(dim/+) population of MM patient PBMCs
Figure S1 from A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
Authors: Chan Wing Keung , Kang Siwen , Youssef Youssef , Glankler Erin N. , Barrett Emma R. , Carter Alex M. , Ahmed Elshafa H. , Prasad Aman , Chen Luxi , Zhang Jianying , Benson Don M. , Caligiuri Michael A. , Yu Jianhua
Published: April 2023

Protein design of control biAb with CDR3 deleted on the anti-NKG2D scFv
Table S4 from Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study
Authors: Nishida Sumiyuki , Ishikawa Takeshi , Egawa Shinichi , Koido Shigeo , Yanagimoto Hiroaki , Ishii Jun , Kanno Yoshihide , Kokura Satoshi , Yasuda Hiroaki , Oba Mari Saito , Sato Maho , Morimoto Soyoko , Fujiki Fumihiro , Eguchi Hidetoshi , Nagano Hiroaki , Kumanogoh Atsushi , Unno Michiaki , Kon Masanori , Shimada Hideaki , Ito Kei , Homma Sadamu , Oka Yoshihiro , Morita Satoshi , Sugiyama Haruo
Published: April 2023

2nd-line treatment regimen & List of long survivors in GEM group
Table S2 from Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study
Authors: Nishida Sumiyuki , Ishikawa Takeshi , Egawa Shinichi , Koido Shigeo , Yanagimoto Hiroaki , Ishii Jun , Kanno Yoshihide , Kokura Satoshi , Yasuda Hiroaki , Oba Mari Saito , Sato Maho , Morimoto Soyoko , Fujiki Fumihiro , Eguchi Hidetoshi , Nagano Hiroaki , Kumanogoh Atsushi , Unno Michiaki , Kon Masanori , Shimada Hideaki , Ito Kei , Homma Sadamu , Oka Yoshihiro , Morita Satoshi , Sugiyama Haruo
Published: April 2023

FACT-G subscale by treatment group
Figure S1 from Immune-Checkpoint Blockade Opposes CD8+ T-cell Suppression in Human and Murine Cancer
Authors: Pfannenstiel Lukas W. , Diaz-Montero C. Marcela , Tian Ye F. , Scharpf Joseph , Ko Jennifer S. , Gastman Brian R.
Published: April 2023

Supplementary Figure 1 A. Dot plots displaying ungated staining of CD8+ CD27/CD28- T cells FACS sorted from human SCCHN tumor tissue and used in Figure 1D. B. Staining of CD8+ PD-1+ Tim-3+ T cells FACS sorted from dissociated human SCCHN tumor tissue and used in Figure 1E. C. Staining of CD8+ T cells purified from dissociated TC-1 tumors by magnetic bead positive selection using the indicated antibodies. D. Ungated staining of the PD-1+/Tim-3+, PD-1+/Tim-3-, and PD-1-/Tim-3- cells FACS sorted from CD3+ CD8+ T cells in dissociated TC-1 tumors.
Supplementary Figure S1 from Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Authors: Shrimali Rajeev K. , Ahmad Shamim , Verma Vivek , Zeng Peng , Ananth Sudha , Gaur Pankaj , Gittelman Rachel M. , Yusko Erik , Sanders Catherine , Robins Harlan , Hammond Scott A. , Janik John E. , Mkrtichyan Mikayel , Gupta Seema , Khleif Samir N.
Published: April 2023

Evaluation of expression of OX40, PD-1, and PD-L1 and proliferation and apoptosis in CD8+ T-cells in vitro.
Figure S5 from Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part Sarcoma
Authors: Lewin Jeremy , Davidson Scott , Anderson Nathaniel D. , Lau Beatrice Y. , Kelly Jacalyn , Tabori Uri , Salah Samer , Butler Marcus O. , Aung Kyaw L. , Shlien Adam , Dickson Brendan C. , Abdul Razak Albiruni R.
Published: April 2023

Ratio of Substitution/indels
Figure S2 from Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part Sarcoma
Authors: Lewin Jeremy , Davidson Scott , Anderson Nathaniel D. , Lau Beatrice Y. , Kelly Jacalyn , Tabori Uri , Salah Samer , Butler Marcus O. , Aung Kyaw L. , Shlien Adam , Dickson Brendan C. , Abdul Razak Albiruni R.
Published: April 2023

Immunohistochemistry in MLH1, MSH2, MSH6 and PMS2 showed intact IHC expression in Patient 1 (magnification: 200x).
Supplementary Figure 1 from Combination Therapy Using Ruxolitinib and Oncolytic HSV Renders Resistant MPNSTs Susceptible to Virotherapy
Authors: Ghonime Mohammed G. , Cassady Kevin A.
Published: April 2023

Supplementary Figure 1: RUX does not impair 67C-4 MPNST tumor cell growth
Supplementary Figure S5 from Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner
Authors: Eissmann Moritz F. , Dijkstra Christine , Wouters Merridee A. , Baloyan David , Mouradov Dmitri , Nguyen Paul M. , Davalos-Salas Mercedes , Putoczki Tracy L. , Sieber Oliver M. , Mariadason John M. , Ernst Matthias , Masson Frederick
Published: April 2023

Fig S5. Loss of IL-33 signalling does not affect the recruitment of macrophages, mast cells and total T cells to the colon tumors.
Supplementary Figure S2 from Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner
Authors: Eissmann Moritz F. , Dijkstra Christine , Wouters Merridee A. , Baloyan David , Mouradov Dmitri , Nguyen Paul M. , Davalos-Salas Mercedes , Putoczki Tracy L. , Sieber Oliver M. , Mariadason John M. , Ernst Matthias , Masson Frederick
Published: April 2023

Fig S2. MC38 tumor growth is enhanced in St2-deficient hosts.
Supplementary Figures from IL13-Mediated Dectin-1 and Mannose Receptor Overexpression Promotes Macrophage Antitumor Activities through Recognition of Sialylated Tumor Cells
Authors: Alaeddine Mohamad , Prat Mélissa , Poinsot Véréna , Gouazé-Andersson Valérie , Authier Hélène , Meunier Etienne , Lefèvre Lise , Alric Camille , Dardenne Christophe , Bernad José , Alric Laurent , Segui Bruno , Balard Patricia , Couderc François , Couderc Bettina , Pipy Bernard , Coste Agnès
Published: April 2023

Figure S1-Figure S8
Supplementary Table 1 from Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
Authors: Castiello Luciano , Sestili Paola , Schiavoni Giovanna , Dattilo Rosanna , Monque Domenica M. , Ciaffoni Fiorella , Iezzi Manuela , Lamolinara Alessia , Sistigu Antonella , Moschella Federica , Pacca Anna Maria , Macchia Daniele , Ferrantini Maria , Zeuner Ann , Biffoni Mauro , Proietti Enrico , Belardelli Filippo , Aricò Eleonora
Published: April 2023

Expression of putative CSC markers in neuT vs IFNAR-neuT tumors
Figure S3 from The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia
Authors: Nuebling Tina , Schumacher Carla Emilia , Hofmann Martin , Hagelstein Ilona , Schmiedel Benjamin Joachim , Maurer Stefanie , Federmann Birgit , Rothfelder Kathrin , Roerden Malte , Dörfel Daniela , Schneider Pascal , Jung Gundram , Salih Helmut Rainer
Published: April 2023

Individual data of cytokine release and metabolic activity upon OX40 stimulation of AML cells.
Table S6 from Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center
Authors: Lisberg Aaron , Tucker D. Andrew , Goldman Jonathan W. , Wolf Brian , Carroll James , Hardy Ariana , Morris Karolyn , Linares Paulina , Adame Carlos , Spiegel Marshall L. , Wells Courtney , McKenzie Jordan , Ledezma Blanca , Mendenhall Melody , Abarca Phillip , Bornazyan Krikor , Hunt Jaime , Moghadam Nima , Chong Natalie , Nameth Danielle , Marx Caitlin , Madrigal John , Vangala Sitaram , Shaverdian Narek , Elashoff David , Garon Edward B.
Published: April 2023

Supplementary Table S6a: Objective response rate (ORR) in the 95 NSCLC patients from the UCLA cohort that had at least 1 set of thyroid values obtained on trial available for analysis stratified by the presence or absence of an abnormal TSH value of varying qualities (Any, High, Low, Both High and Low noted).
Table S4 from Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center
Authors: Lisberg Aaron , Tucker D. Andrew , Goldman Jonathan W. , Wolf Brian , Carroll James , Hardy Ariana , Morris Karolyn , Linares Paulina , Adame Carlos , Spiegel Marshall L. , Wells Courtney , McKenzie Jordan , Ledezma Blanca , Mendenhall Melody , Abarca Phillip , Bornazyan Krikor , Hunt Jaime , Moghadam Nima , Chong Natalie , Nameth Danielle , Marx Caitlin , Madrigal John , Vangala Sitaram , Shaverdian Narek , Elashoff David , Garon Edward B.
Published: April 2023

Supplementary Table 4a: Objective response rate (ORR), progression-free survival (PFS), and overall survival stratified by the incidence of a grade 2 or higher treatment related AE (trAE) or a trAE of varying degrees of attribution (possible or probable). Included are all 97 NSCLC patients treated at UCLA on KEYNOTE-001 with available follow-up data.
Figure S1 from Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center
Authors: Lisberg Aaron , Tucker D. Andrew , Goldman Jonathan W. , Wolf Brian , Carroll James , Hardy Ariana , Morris Karolyn , Linares Paulina , Adame Carlos , Spiegel Marshall L. , Wells Courtney , McKenzie Jordan , Ledezma Blanca , Mendenhall Melody , Abarca Phillip , Bornazyan Krikor , Hunt Jaime , Moghadam Nima , Chong Natalie , Nameth Danielle , Marx Caitlin , Madrigal John , Vangala Sitaram , Shaverdian Narek , Elashoff David , Garon Edward B.
Published: April 2023

Supplementary Figure S1A-B. ORR, PFS, and OS analysis for UCLA NSCLC cohort of KEYNOTE-001 trial. ORR, PFS, and OS for all 97 patients in the UCLA cohort of the KEYNOTE-001 trial stratified by the occurrence of a (A) treatment related adverse event (trAE) or (B) a treatment related select AE.
Supplementary Table 1 from Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile
Authors: Querfeld Christiane , Leung Samantha , Myskowski Patricia L. , Curran Shane A. , Goldman Debra A. , Heller Glenn , Wu Xiwei , Kil Sung Hee , Sharma Sneh , Finn Kathleen J. , Horwitz Steven , Moskowitz Alison , Mehrara Babak , Rosen Steven T. , Halpern Allan C. , Young James W.
Published: April 2023

Numbers and ratios of dendritic cells and T cells migrated from skin explants
Figure S2 from NK Cell–Specific CDK8 Deletion Enhances Antitumor Responses
Authors: Witalisz-Siepracka Agnieszka , Gotthardt Dagmar , Prchal-Murphy Michaela , Didara Zrinka , Menzl Ingeborg , Prinz Daniela , Edlinger Leo , Putz Eva Maria , Sexl Veronika
Published: April 2023

S2. Quantification of perforin and granzyme B western blot from Fig. 2 and ex vivo cytotoxicity assay.
Table S2 from CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma
Authors: Samaniego Rafael , Gutiérrez-González Alejandra , Gutiérrez-Seijo Alba , Sánchez-Gregorio Sandra , García-Giménez Jorge , Mercader Enrique , Márquez-Rodas Iván , Avilés José Antonio , Relloso Miguel , Sánchez-Mateos Paloma
Published: April 2023

Supplementary Table S2. Melanoma patient characteristics.
Figure S3 from CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma
Authors: Samaniego Rafael , Gutiérrez-González Alejandra , Gutiérrez-Seijo Alba , Sánchez-Gregorio Sandra , García-Giménez Jorge , Mercader Enrique , Márquez-Rodas Iván , Avilés José Antonio , Relloso Miguel , Sánchez-Mateos Paloma
Published: April 2023

Supplementary Figure S3. DC and TAM subsets in melanoma tissues.
Figure S2 from CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma
Authors: Samaniego Rafael , Gutiérrez-González Alejandra , Gutiérrez-Seijo Alba , Sánchez-Gregorio Sandra , García-Giménez Jorge , Mercader Enrique , Márquez-Rodas Iván , Avilés José Antonio , Relloso Miguel , Sánchez-Mateos Paloma
Published: April 2023

Supplementary Figure S2. TAM CD14+/CD163+ are the major source of CCL20 in human melanoma.
Figure S1 from CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma
Authors: Samaniego Rafael , Gutiérrez-González Alejandra , Gutiérrez-Seijo Alba , Sánchez-Gregorio Sandra , García-Giménez Jorge , Mercader Enrique , Márquez-Rodas Iván , Avilés José Antonio , Relloso Miguel , Sánchez-Mateos Paloma
Published: April 2023

Supplementary Figure S1. CCR6 expression, melanoma xenograft model and in vivo effects of exogenous CCL20.
Supplementary Figure Legends from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Authors: Vicioso Yorleny , Gram Hermann , Beck Rose , Asthana Abhishek , Zhang Keman , Wong Derek P. , Letterio John , Parameswaran Reshmi
Published: April 2023

Supplementary Figure Legends
Figure 1S from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Authors: Vicioso Yorleny , Gram Hermann , Beck Rose , Asthana Abhishek , Zhang Keman , Wong Derek P. , Letterio John , Parameswaran Reshmi
Published: April 2023

Supp. Fig. 1 ALL sample characteristics. A, Summary data from 11 adults and 5 pediatric ALL patients. Genetic and diagnostic information was provided by clinical pathologist Rose Beck at University Hospitals Medical Center (UHMC). BAFF-R expression was determined by FACs analysis of gated CD19+, CD10+ cells (each sample represents an independent experiment). B, mRNA BAFF-R expression levels in ALL cells relative to GAPDH (mean {plus minus} SEM of 3 technical replicates). C, Representative FACs analysis (left) and percentages (right) of BAFF-R expression in PBMCs, gated B-cells (CD19+CD3-), T-cells (CD3+, CD19-, CD56-), and NK cells (CD56+, CD3-). The data represent the mean {plus minus} SEM of 3 technical replicates of 4 healthy donors from 2 independent experiments. D, Viability of relapse PhÃ,Â­ (PT-2) and drug resistant Ph+ (PTÃ,Â­3 & PTÃ,Â­4) ALL cells after treatment with either vincristine (2.5 nM) or nilotinib (300 nM) at the indicated time points. The data represent the mean {plus minus} SEM of 4 independent experiments with 3 technical replicates.
Supplementary Table 2 from Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages
Authors: Limagne Emeric , Thibaudin Marion , Nuttin Lisa , Spill Aodrenn , Derangère Valentin , Fumet Jean-David , Amellal Nadia , Peranzoni Elisa , Cattan Valérie , Ghiringhelli François
Published: April 2023

Supplementary Table 2
Supplementary Figure Legend from Targeted Delivery of IL2 to the Tumor Stroma Potentiates the Action of Immune Checkpoint Inhibitors by Preferential Activation of NK and CD8+ T Cells
Authors: Hutmacher Cornelia , Gonzalo Núñez Nicolás , Liuzzi Anna Rita , Becher Burkhard , Neri Dario
Published: April 2023

Supplementary Figure Legend
Supplementary Table 4 from Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression
Authors: Cavalleri Tommaso , Bianchi Paolo , Basso Gianluca , Celesti Giuseppe , Grizzi Fabio , Bossi Paola , Greco Luana , Pitrone Calogero , Valtorta Emanuele , Mauri Gianluca , Truini Mauro , Dall'Olio Filippo Gustavo , Brandi Giovanni , Sartore-Bianchi Andrea , Ricciardiello Luigi , Torri Valter , Rimassa Lorenza , Siena Salvatore , Mantovani Alberto , Malesci Alberto , Laghi Luigi
Published: April 2023

Low densities of FoxP3+ and CD3+ TILs, and their combination, to predict disease-free survival (DFS) in stage II MSS CRC Validation set.
Supplementary Table S1 from Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma
Authors: Lesokhin Alexander M. , Bal Susan , Badros Ashraf Z.
Published: April 2023

Table S1
Supplementary Figures and Tables from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
Authors: Xiong Huizhong , Mittman Stephanie , Rodriguez Ryan , Pacheco-Sanchez Patricia , Moskalenko Marina , Yang Yagai , Elstrott Justin , Ritter Alex T. , Müller Sören , Nickles Dorothee , Arenzana Teresita L. , Capietto Aude-Hélène , Delamarre Lélia , Modrusan Zora , Rutz Sascha , Mellman Ira , Cubas Rafael
Published: April 2023

Supplemental Figures Showing: Fig. S1: CD8 T cells co-expressing PD1, LAG3 and TIM3 are present at different frequencies in MC38 and EMT6 tumors and represent activated cells. Fig. S2: CD8 T cells co-expressing inhibitory receptors are enriched in antigen-experienced and activated cells relative to the PD1- subset. Fig. S3: Majority of CD8 T cells in blood of MC38 and EMT6 tumor bearing mice lack PD1 and T-bet expression. Fig. S4: Anti-PD-L1 treatment increases the activity and cytolytic potential of PD1+ CD8 T cell subsets in MC38 and EMT6 tumors. Fig. S5: JC and 4T1 tumors do not respond to anti-PD-L1 treatment. Fig. S6: CD8 T cells co-expressing PD1, LAG3 and TIM3 are highly activated in JC and 4T1 tumors. Table S1: List of flow cytometry markers used for univariate linear regression analysis in Supplementary table 2. Table S2: Top parameters correlated with response to anti-PD-L1.
Movie S2 from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
Authors: Xiong Huizhong , Mittman Stephanie , Rodriguez Ryan , Pacheco-Sanchez Patricia , Moskalenko Marina , Yang Yagai , Elstrott Justin , Ritter Alex T. , Müller Sören , Nickles Dorothee , Arenzana Teresita L. , Capietto Aude-Hélène , Delamarre Lélia , Modrusan Zora , Rutz Sascha , Mellman Ira , Cubas Rafael
Published: April 2023

Cytotoxicity assay with sorted PD1- CD8 T cells
Table S6 from The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes
Authors: Pfannstiel Carolin , Strissel Pamela L. , Chiappinelli Katherine B. , Sikic Danijel , Wach Sven , Wirtz Ralph M. , Wullweber Adrian , Taubert Helge , Breyer Johannes , Otto Wolfgang , Worst Thomas , Burger Maximilian , Wullich Bernd , Bolenz Christian , Fuhrich Nicole , Geppert Carol I. , Weyerer Veronika , Stoehr Robert , Bertz Simone , Keck Bastian , Erlmeier Franziska , Erben Philipp , Hartmann Arndt , Strick Reiner , Eckstein Markus
Published: April 2023

Multivariable Survival Models.
TableS5 from Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma
Authors: Xiang Handan , Ramil Carlo P. , Hai Josephine , Zhang Chunsheng , Wang Huijun , Watkins Amanda A. , Afshar Roshi , Georgiev Peter , Sze Marc A. , Song Xuelei S. , Curran Patrick J. , Cheng Mangeng , Miller J. Richard , Sun Dongyu , Loboda Andrey , Jia Yanlin , Moy Lily Y. , Chi An , Brandish Philip E.
Published: April 2023

Supplementary table 5
Table S1 from Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma
Authors: Xiang Handan , Ramil Carlo P. , Hai Josephine , Zhang Chunsheng , Wang Huijun , Watkins Amanda A. , Afshar Roshi , Georgiev Peter , Sze Marc A. , Song Xuelei S. , Curran Patrick J. , Cheng Mangeng , Miller J. Richard , Sun Dongyu , Loboda Andrey , Jia Yanlin , Moy Lily Y. , Chi An , Brandish Philip E.
Published: April 2023

Supplementary table 1
Supplementary Tables 1-6, 8 from A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
Authors: Workel Hagma H. , Lubbers Joyce M. , Arnold Roland , Prins Thalina M. , van der Vlies Pieter , de Lange Kim , Bosse Tjalling , van Gool Inge C. , Eggink Florine A. , Wouters Maartje C.A. , Komdeur Fenne L. , van der Slikke Elisabeth C. , Creutzberg Carien L. , Kol Arjan , Plat Annechien , Glaire Mark , Church David N. , Nijman Hans W. , de Bruyn Marco
Published: April 2023

Supplementary Tables 1-6, 8
Supplementary Table 7 from A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
Authors: Workel Hagma H. , Lubbers Joyce M. , Arnold Roland , Prins Thalina M. , van der Vlies Pieter , de Lange Kim , Bosse Tjalling , van Gool Inge C. , Eggink Florine A. , Wouters Maartje C.A. , Komdeur Fenne L. , van der Slikke Elisabeth C. , Creutzberg Carien L. , Kol Arjan , Plat Annechien , Glaire Mark , Church David N. , Nijman Hans W. , de Bruyn Marco
Published: April 2023

Supplementary Table 7. Differential expression analysis of CD103+ vs CD103- CD8+ cytotoxic T cells
Figure S2 from Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity
Authors: Kroon Paula , Frijlink Elselien , Iglesias-Guimarais Victoria , Volkov Andriy , van Buuren Marit M. , Schumacher Ton N. , Verheij Marcel , Borst Jannie , Verbrugge Inge
Published: April 2023

Depletion of effector phenotype T cells from the circulation following RIT combined with FTY720 treatment.
Figure S2 from Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
Authors: Longino Natalie V. , Yang Junbao , Iyer Jayasri G. , Ibrani Dafina , Chow I-Ting , Laing Kerry J. , Campbell Victoria L. , Paulson Kelly G. , Kulikauskas Rima M. , Church Candice D. , James Eddie A. , Nghiem Paul , Kwok William W. , Koelle David M.
Published: April 2023

CFSE dilution for epitope discovery
Figure S1 from Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain
Authors: Longino Natalie V. , Yang Junbao , Iyer Jayasri G. , Ibrani Dafina , Chow I-Ting , Laing Kerry J. , Campbell Victoria L. , Paulson Kelly G. , Kulikauskas Rima M. , Church Candice D. , James Eddie A. , Nghiem Paul , Kwok William W. , Koelle David M.
Published: April 2023

ICS detects MCPyV-specific response in TIL from an MCC patients
Supplementary Figures from Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors
Authors: Teh Jessica L.F. , Erkes Dan A. , Cheng Phil F. , Tiago Manoela , Wilski Nicole A. , Field Conroy O. , Chervoneva Inna , Levesque Mitch P. , Xu Xiaowei , Dummer Reinhard , Aplin Andrew E.
Published: April 2023

Supplementary Figures
Supplementary Table 1 from Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice
Authors: Poh Ashleigh R. , Dwyer Amy R. , Eissmann Moritz F. , Chand Ashwini L. , Baloyan David , Boon Louis , Murrey Michael W. , Whitehead Lachlan , O'Brien Megan , Lowell Clifford A. , Putoczki Tracy L. , Pixley Fiona J. , O'Donoghue Robert J.J. , Ernst Matthias
Published: April 2023

Supplementary Table 1
Supplementary Figure 4 from Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice
Authors: Poh Ashleigh R. , Dwyer Amy R. , Eissmann Moritz F. , Chand Ashwini L. , Baloyan David , Boon Louis , Murrey Michael W. , Whitehead Lachlan , O'Brien Megan , Lowell Clifford A. , Putoczki Tracy L. , Pixley Fiona J. , O'Donoghue Robert J.J. , Ernst Matthias
Published: April 2023

Excessive HCK activity in bone marrow-derived cells promotes STAT3-dependent gastric tumor development and invasion.
Supplementary Figure 2 from Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice
Authors: Poh Ashleigh R. , Dwyer Amy R. , Eissmann Moritz F. , Chand Ashwini L. , Baloyan David , Boon Louis , Murrey Michael W. , Whitehead Lachlan , O'Brien Megan , Lowell Clifford A. , Putoczki Tracy L. , Pixley Fiona J. , O'Donoghue Robert J.J. , Ernst Matthias
Published: April 2023

Increased HCK activity in BMDMs supports tumor cell invasion in vitro.
Supplementary Tables from Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer
Authors: Tosti Nadia , Cremonesi Eleonora , Governa Valeria , Basso Camilla , Kancherla Venkatesh , Coto-Llerena Mairene , Amicarella Francesca , Weixler Benjamin , Däster Silvio , Sconocchia Giuseppe , Majno Pietro Edoardo , Christoforidis Dimitri , Tornillo Luigi , Terracciano Luigi , Ng Charlotte K.Y. , Piscuoglio Salvatore , von Flüe Markus , Spagnoli Giulio , Eppenberger-Castori Serenella , Iezzi Giandomenica , Droeser Raoul Andre
Published: April 2023

Supplementary Tables 1-5
Supplementary Table S5 from Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy
Authors: Lu Yong-Chen , Jia Li , Zheng Zhili , Tran Eric , Robbins Paul F. , Rosenberg Steven A.
Published: April 2023

Supplementary Table S5
Supplementary Data from Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma
Authors: Kim Amy K. , Gani Faiz , Layman Andrew J. , Besharati Sepideh , Zhu Qingfeng , Succaria Farah , Engle Elizabeth L. , Bhaijee Feriyl , Goggins Maria B. , Llosa Nicolas J. , Pawlik Timothy M. , Yarchoan Mark , Jaffee Elizabeth M. , Simons Howard C. , Taube Janis M. , Anders Robert A.
Published: April 2023

Supplemental Tables 1-3 and Supplemental Figure 1
Supplementary Figure Legends from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
Authors: Di Tacchio Mariangela , Macas Jadranka , Weissenberger Jakob , Sommer Kathleen , Bähr Oliver , Steinbach Joachim P. , Senft Christian , Seifert Volker , Glas Martin , Herrlinger Ulrich , Krex Dietmar , Meinhardt Matthias , Weyerbrock Astrid , Timmer Marco , Goldbrunner Roland , Deckert Martina , Scheel Andreas H. , Büttner Reinhard , Grauer Oliver M. , Schittenhelm Jens , Tabatabai Ghazaleh , Harter Patrick N. , Günther Stefan , Devraj Kavi , Plate Karl H. , Reiss Yvonne
Published: April 2023

Supplementary Figure Legends 1 - 3 are displayed
Supplementary Figure 4 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
Authors: Di Tacchio Mariangela , Macas Jadranka , Weissenberger Jakob , Sommer Kathleen , Bähr Oliver , Steinbach Joachim P. , Senft Christian , Seifert Volker , Glas Martin , Herrlinger Ulrich , Krex Dietmar , Meinhardt Matthias , Weyerbrock Astrid , Timmer Marco , Goldbrunner Roland , Deckert Martina , Scheel Andreas H. , Büttner Reinhard , Grauer Oliver M. , Schittenhelm Jens , Tabatabai Ghazaleh , Harter Patrick N. , Günther Stefan , Devraj Kavi , Plate Karl H. , Reiss Yvonne
Published: April 2023

Gating strategy for the delineation of glioma tumor infiltrating lymphocytes.
Movie 3 from Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
Authors: Di Tacchio Mariangela , Macas Jadranka , Weissenberger Jakob , Sommer Kathleen , Bähr Oliver , Steinbach Joachim P. , Senft Christian , Seifert Volker , Glas Martin , Herrlinger Ulrich , Krex Dietmar , Meinhardt Matthias , Weyerbrock Astrid , Timmer Marco , Goldbrunner Roland , Deckert Martina , Scheel Andreas H. , Büttner Reinhard , Grauer Oliver M. , Schittenhelm Jens , Tabatabai Ghazaleh , Harter Patrick N. , Günther Stefan , Devraj Kavi , Plate Karl H. , Reiss Yvonne
Published: April 2023

Aflibercept/AMG386 therapy renders a normalize vasculature with improved pericyte coverage (CollagenIV, red; desmin, green)
Supplementary Table from Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
Authors: Tannenbaum Charles S. , Rayman Patricia A. , Pavicic Paul G. , Kim Jin Sub , Wei Wei , Polefko Alexandra , Wallace Wesley , Rini Brian I. , Morris-Stiff Gareth , Allende Daniela S. , Hamilton Thomas , Finke James H. , Diaz-Montero C. Marcela
Published: April 2023

Supplementary Table S1
Supplementary Table 1 from The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages
Authors: Li Chunjie , Xue Vivian Weiwen , Wang Qing-Ming , Lian Guang-Yu , Huang Xiao-Ru , Lee Tin-Lap , To Ka-Fai , Tang Patrick Ming-Kuen , Lan Hui-Yao
Published: April 2023

Table S1
Supplementary Figures S1 to S10 from The Mincle/Syk/NF-κB Signaling Circuit Is Essential for Maintaining the Protumoral Activities of Tumor-Associated Macrophages
Authors: Li Chunjie , Xue Vivian Weiwen , Wang Qing-Ming , Lian Guang-Yu , Huang Xiao-Ru , Lee Tin-Lap , To Ka-Fai , Tang Patrick Ming-Kuen , Lan Hui-Yao
Published: April 2023

Figures S1 to S10
Figure S2 from CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
Authors: Wennhold Kerstin , Thelen Martin , Lehmann Jonas , Schran Simon , Preugszat Ella , Garcia-Marquez Maria , Lechner Axel , Shimabukuro-Vornhagen Alexander , Ercanoglu Meryem S. , Klein Florian , Thangarajah Fabinshy , Eidt Sebastian , Löser Heike , Bruns Christiane , Quaas Alexander , von Bergwelt-Baildon Michael , Schlößer Hans A.
Published: April 2023

Supplementary Figure 2: Gating strategy for flow cytometry. Live CD45+ cells were gated after live/dead discrimination and removal of doublets as shown.
Supplementary Figures from Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers
Authors: Galliverti Gabriele , Wullschleger Stephan , Tichet Mélanie , Murugan Dhaarini , Zangger Nadine , Horton Wesley , Korman Alan J. , Coussens Lisa M. , Swartz Melody A. , Hanahan Douglas
Published: April 2023

Supplementary Figures
Figure S1 from CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
Authors: Wennhold Kerstin , Thelen Martin , Lehmann Jonas , Schran Simon , Preugszat Ella , Garcia-Marquez Maria , Lechner Axel , Shimabukuro-Vornhagen Alexander , Ercanoglu Meryem S. , Klein Florian , Thangarajah Fabinshy , Eidt Sebastian , Löser Heike , Bruns Christiane , Quaas Alexander , von Bergwelt-Baildon Michael , Schlößer Hans A.
Published: April 2023

Supplementary Figure 1: : Single-cell suspensions of tumor draining lymph nodes of colorectal cancer patients (n=10) were stained via antigen tetramers for CEA-specific B cells.
Supplementary Figures from Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment
Authors: Leister Hanna , Luu Maik , Staudenraus Daniel , Lopez Krol Aleksandra , Mollenkopf Hans-Joachim , Sharma Arjun , Schmerer Nils , Schulte Leon N. , Bertrams Wilhelm , Schmeck Bernd , Bosmann Markus , Steinhoff Ulrich , Visekruna Alexander
Published: April 2023

Supplementary Figures 1-9
Supplementary Figures from Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses
Authors: Pilones Karsten A. , Charpentier Maud , Garcia-Martinez Elena , Daviaud Camille , Kraynak Jeffrey , Aryankalayil Joseph , Formenti Silvia C. , Demaria Sandra
Published: April 2023

Supplementary Figures 1-4
Supplementary Table 3 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift
Authors: Mayerhoefer Marius E. , Haug Alexander , Jäger Ulrich , Pichler Verena , Pfaff Sarah , Wester Hans-Jürgen , Hacker Marcus , Kazianka Lukas , Staber Philipp B.
Published: April 2023

Imaging parameters and white blood cell counts before and at mid- and long-term follow-up on ibrutinib treatment
Supplementary Table 5 from T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models
Authors: Morello Gaia , Cancila Valeria , La Rosa Massimo , Germano Giovanni , Lecis Daniele , Amodio Vito , Zanardi Federica , Iannelli Fabio , Greco Daniele , La Paglia Laura , Fiannaca Antonino , Urso Alfonso M. , Graziano Giulia , Ferrari Francesco , Pupa Serenella M. , Sangaletti Sabina , Chiodoni Claudia , Pruneri Giancarlo , Bardelli Alberto , Colombo Mario P. , Tripodo Claudio
Published: April 2023

Supplementary Table 5
Supplementary Table 1 from In Human Visualization of Ibrutinib-Induced CLL Compartment Shift
Authors: Mayerhoefer Marius E. , Haug Alexander , Jäger Ulrich , Pichler Verena , Pfaff Sarah , Wester Hans-Jürgen , Hacker Marcus , Kazianka Lukas , Staber Philipp B.
Published: April 2023

Patients' characteristics
Supplementary Table 2 from T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models
Authors: Morello Gaia , Cancila Valeria , La Rosa Massimo , Germano Giovanni , Lecis Daniele , Amodio Vito , Zanardi Federica , Iannelli Fabio , Greco Daniele , La Paglia Laura , Fiannaca Antonino , Urso Alfonso M. , Graziano Giulia , Ferrari Francesco , Pupa Serenella M. , Sangaletti Sabina , Chiodoni Claudia , Pruneri Giancarlo , Bardelli Alberto , Colombo Mario P. , Tripodo Claudio
Published: April 2023

Supplementary Table 2
Supplementary Table 1 from T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models
Authors: Morello Gaia , Cancila Valeria , La Rosa Massimo , Germano Giovanni , Lecis Daniele , Amodio Vito , Zanardi Federica , Iannelli Fabio , Greco Daniele , La Paglia Laura , Fiannaca Antonino , Urso Alfonso M. , Graziano Giulia , Ferrari Francesco , Pupa Serenella M. , Sangaletti Sabina , Chiodoni Claudia , Pruneri Giancarlo , Bardelli Alberto , Colombo Mario P. , Tripodo Claudio
Published: April 2023

Supplementary Table 1
Supplementary Data from Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Authors: Badeaux Mark D. , Rolig Annah S. , Agnello Giulia , Enzler Danlee , Kasiewicz Melissa J. , Priddy Leslie , Wiggins Jason F. , Muir Alexander , Sullivan Mark R. , Van Cleef Jessica , Daige Christopher , Vander Heiden Matthew G. , Rajamanickam Venkatesh , Wooldridge James E. , Redmond William L. , Rowlinson Scott W.
Published: April 2023

Supplemental Table S1
Supplemental Figures from Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Authors: Badeaux Mark D. , Rolig Annah S. , Agnello Giulia , Enzler Danlee , Kasiewicz Melissa J. , Priddy Leslie , Wiggins Jason F. , Muir Alexander , Sullivan Mark R. , Van Cleef Jessica , Daige Christopher , Vander Heiden Matthew G. , Rajamanickam Venkatesh , Wooldridge James E. , Redmond William L. , Rowlinson Scott W.
Published: April 2023

Supplemental Figures
Supplementary Figure S3 from Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
Authors: Emmons Tiffany R. , Giridharan Thejaswini , Singel Kelly L. , Khan ANM Nazmul H. , Ricciuti Jason , Howard Kaitlyn , Silva-Del Toro Stephanie L. , Debreceni Ivy L. , Aarts Cathelijn E.M. , Brouwer Mieke C. , Suzuki Sora , Kuijpers Taco W. , Jongerius Ilse , Allen Lee-Ann H. , Ferreira Viviana P. , Schubart Anna , Sellner Holger , Eder Jörg , Holland Steven M. , Ram Sanjay , Lederer James A. , Eng Kevin H. , Moysich Kirsten B. , Odunsi Kunle , Yaffe Michael B. , Zsiros Emese , Segal Brahm H.
Published: April 2023

Supplementary Figure S3: OC ascites fluid activates the classical and alternative pathways.
Supplementary Table S5 from Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer
Authors: Heath Owen , Berlato Chiara , Maniati Eleni , Lakhani Anissa , Pegrum Colin , Kotantaki Panoraia , Elorbany Samar , Böhm Steffen , Barry Simon T. , Annibaldi Alessandro , Barton Desmond P. , Balkwill Frances R.
Published: April 2023

List of GSEA canonical pathways and gene ontologies in AZD vs Ctrl
Supplementary Figure S1 from Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
Authors: Emmons Tiffany R. , Giridharan Thejaswini , Singel Kelly L. , Khan ANM Nazmul H. , Ricciuti Jason , Howard Kaitlyn , Silva-Del Toro Stephanie L. , Debreceni Ivy L. , Aarts Cathelijn E.M. , Brouwer Mieke C. , Suzuki Sora , Kuijpers Taco W. , Jongerius Ilse , Allen Lee-Ann H. , Ferreira Viviana P. , Schubart Anna , Sellner Holger , Eder Jörg , Holland Steven M. , Ram Sanjay , Lederer James A. , Eng Kevin H. , Moysich Kirsten B. , Odunsi Kunle , Yaffe Michael B. , Zsiros Emese , Segal Brahm H.
Published: April 2023

Supplementary Figure S1: Gating strategies for flow cytometry and Image-stream.
Figure S5 from Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer
Authors: Nair Nitya , Chen Shih-Yu , Lemmens Ed , Chang Serena , Le Dung T. , Jaffee Elizabeth M. , Murphy Aimee , Whiting Chan , Müller Thomas , Brockstedt Dirk G.
Published: April 2023

Measurement of the frequencies of CD8+CD45RO-CCR7-CD57+ and CD14+CD33+CD85j+ by flow cytometry and mass cytometry
Supplementary Table 1 from Immunosuppressive Myeloid Cells Induce Nitric Oxide–Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells
Authors: Cartwright Adam N.R. , Suo Shengbao , Badrinath Soumya , Kumar Sushil , Melms Johannes , Luoma Adrienne , Bagati Archis , Saadatpour Assieh , Izar Benjamin , Yuan Guo-Cheng , Wucherpfennig Kai W.
Published: April 2023

Supplementary Table 1. Summary of proposed mechanisms of MDSC-mediated suppression.
Supplementary Figure Legends from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
Authors: Edwards Jarem , Ferguson Peter M. , Lo Serigne N. , Pires da Silva Inês , Colebatch Andrew J. , Lee Hansol , Saw Robyn P.M. , Thompson John F. , Menzies Alexander M. , Long Georgina V. , Newell Felicity , Pearson John V. , Waddell Nicola , Hayward Nicholas K. , Johansson Peter A. , Mann Graham J. , Scolyer Richard A. , Palendira Umaimainthan , Wilmott James S.
Published: April 2023

Legends for Supplementary Figures
Supplementary Data from Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy
Authors: Veliça Pedro , Cunha Pedro P. , Vojnovic Nikola , Foskolou Iosifina Petrina , Bargiela David , Gojkovic Milos , Rundqvist Helene , Johnson Randall S.
Published: April 2023

Supplementary Figures 1-5 and Legends, Supplemental Table 1
Supplementary Figures from Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model
Authors: Ager Casey R. , Obradovic Aleksandar Z. , Arriaga Juan M. , Chaimowitz Matthew G. , Califano Andrea , Abate-Shen Cory , Drake Charles G.
Published: April 2023

Supplementary Figures S1-S7
Supplementary Table S1 from Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
Authors: Lau Tat San , Chan Loucia Kit Ying , Man Gene Chi Wai , Wong Chi Hang , Lee Jacqueline Ho Sze , Yim So Fan , Cheung Tak Hong , McNeish Iain A. , Kwong Joseph
Published: April 2023

Supplementary Table S1
Supplementary Figures and Legends from Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
Authors: Lau Tat San , Chan Loucia Kit Ying , Man Gene Chi Wai , Wong Chi Hang , Lee Jacqueline Ho Sze , Yim So Fan , Cheung Tak Hong , McNeish Iain A. , Kwong Joseph
Published: April 2023

All Supplementary Figures and their respective legends.
Supplementary Figures from IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition
Authors: Treffers Louise W. , ten Broeke Toine , Rösner Thies , Jansen J.H. Marco , van Houdt Michel , Kahle Steffen , Schornagel Karin , Verkuijlen Paul J.J.H. , Prins Jan M. , Franke Katka , Kuijpers Taco W. , van den Berg Timo K. , Valerius Thomas , Leusen Jeanette H.W. , Matlung Hanke L.
Published: April 2023

Supplementary Figures
Supplementary Figures S1-S12 from IDO1 Signaling through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization
Authors: Dey Souvik , Mondal Arpita , DuHadaway James B. , Sutanto-Ward Erika , Laury-Kleintop Lisa D. , Thomas Sunil , Prendergast George C. , Mandik-Nayak Laura , Muller Alexander J.
Published: April 2023

Supplementary Figures S1-S12
Table S5 from Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
Authors: Huetter Julia , Gritzan Uwe , Gutcher Ilona , Doecke Wolf-Dietrich , Luetke-Eversloh Merlin V. , Golfier Sven , Roider Helge G. , Frisk Anna-Lena , Hunter John , Pow Andrew , Drake Andrew , Levine Zurit , Levy Ofer , Azulay Meir , Barbiro Inbal , Cojocaru Gady , Vaknin Ilan , Kreft Bertolt , Roese Lars
Published: April 2023

Histopathological findings in 8 weeks and 12 months old wild-type and ILDR2-deficient C57BL/6mice.
Table S3 from Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
Authors: Huetter Julia , Gritzan Uwe , Gutcher Ilona , Doecke Wolf-Dietrich , Luetke-Eversloh Merlin V. , Golfier Sven , Roider Helge G. , Frisk Anna-Lena , Hunter John , Pow Andrew , Drake Andrew , Levine Zurit , Levy Ofer , Azulay Meir , Barbiro Inbal , Cojocaru Gady , Vaknin Ilan , Kreft Bertolt , Roese Lars
Published: April 2023

Syngeneic mouse models
Supplementary Information from Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2)
Authors: Huetter Julia , Gritzan Uwe , Gutcher Ilona , Doecke Wolf-Dietrich , Luetke-Eversloh Merlin V. , Golfier Sven , Roider Helge G. , Frisk Anna-Lena , Hunter John , Pow Andrew , Drake Andrew , Levine Zurit , Levy Ofer , Azulay Meir , Barbiro Inbal , Cojocaru Gady , Vaknin Ilan , Kreft Bertolt , Roese Lars
Published: April 2023

Supplementary information
Supplementary Figures from Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
Authors: Drijvers Jefte M. , Gillis Jacob E. , Muijlwijk Tara , Nguyen Thao H. , Gaudiano Emily F. , Harris Isaac S. , LaFleur Martin W. , Ringel Alison E. , Yao Cong-Hui , Kurmi Kiran , Juneja Vikram R. , Trombley Justin D. , Haigis Marcia C. , Sharpe Arlene H.
Published: April 2023

Supplementary Figures
Supplementary Table S1 from The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome
Authors: Foroutan Momeneh , Molania Ramyar , Pfefferle Aline , Behrenbruch Corina , Scheer Sebastian , Kallies Axel , Speed Terence P. , Cursons Joseph , Huntington Nicholas D.
Published: April 2023

List of the tools and packages used in the manuscript
Supplementary Data Table S1 from Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils
Authors: Khan ANM Nazmul H. , Emmons Tiffany R. , Wong Jerry T. , Alqassim Emad , Singel Kelly L. , Mark Jaron , Smith Brandon E. , Tario Joseph D. , Eng Kevin H. , Moysich Kirsten B. , Odunsi Kunle , Abrams Scott I. , Segal Brahm H.
Published: April 2023

Anti-human mAb used in flow cytometry analysis and cell sorting for this study.
Table S1 from The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo
Authors: Dreyer Tobias F. , Kuhn Sabine , Stange Christoph , Heithorst Nadine , Schilling Daniela , Jelsma Jil , Sievert Wolfgang , Seitz Stefanie , Stangl Stefan , Hapfelmeier Alexander , Noske Aurelia , Wege Anja K. , Weichert Wilko , Ruland Jürgen , Schmitt Manfred , Dorn Julia , Kiechle Marion , Reuning Ute , Magdolen Viktor , Multhoff Gabriele , Bronger Holger
Published: April 2023

Patient characteristics of the whole breast cancer cohort used for CX3CL1 expression analysis (n=250)
Figure S3 from The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo
Authors: Dreyer Tobias F. , Kuhn Sabine , Stange Christoph , Heithorst Nadine , Schilling Daniela , Jelsma Jil , Sievert Wolfgang , Seitz Stefanie , Stangl Stefan , Hapfelmeier Alexander , Noske Aurelia , Wege Anja K. , Weichert Wilko , Ruland Jürgen , Schmitt Manfred , Dorn Julia , Kiechle Marion , Reuning Ute , Magdolen Viktor , Multhoff Gabriele , Bronger Holger
Published: April 2023

Modulation of CXCL10 secretion from human HER2-positive cancer cell lines upon stimulation with TNF-α and TAPI-2.
Figure S2 from The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer In Vitro and In Vivo
Authors: Dreyer Tobias F. , Kuhn Sabine , Stange Christoph , Heithorst Nadine , Schilling Daniela , Jelsma Jil , Sievert Wolfgang , Seitz Stefanie , Stangl Stefan , Hapfelmeier Alexander , Noske Aurelia , Wege Anja K. , Weichert Wilko , Ruland Jürgen , Schmitt Manfred , Dorn Julia , Kiechle Marion , Reuning Ute , Magdolen Viktor , Multhoff Gabriele , Bronger Holger
Published: April 2023

Figure S2. Impact of Cx3cl1 overexpression on tumor cell growth in vitro, Cx3cl1 serum concentrations, and myeloid cell tumor infiltration in the 4T1 breast cancer model.
Supplementary Figure S1 from TGFβ Programs Central Memory Differentiation in Ex Vivo–Stimulated Human T Cells
Authors: Dahmani Amina , Janelle Valérie , Carli Cédric , Richaud Manon , Lamarche Caroline , Khalili Myriam , Goupil Mathieu , Bezverbnaya Ksenia , Bramson Jonathan L. , Delisle Jean-Sébastien
Published: April 2023

SMAD3 phosphorylation
Supplementary Figures from Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy
Authors: Kagoya Yuki , Guo Tingxi , Yeung Brian , Saso Kayoko , Anczurowski Mark , Wang Chung-Hsi , Murata Kenji , Sugata Kenji , Saijo Hiroshi , Matsunaga Yukiko , Ohashi Yota , Butler Marcus O. , Hirano Naoto
Published: April 2023

Figures S1-S6
Supplementary Materials from Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention
Authors: Jacqueline Camille , Lee Amanda , Frey Nolan , Minden Jonathan S. , Finn Olivera J.
Published: April 2023

Figures and Tables
Supplementary Figures from A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies
Authors: de Weerdt Iris , Lameris Roeland , Scheffer George L. , Vree Jana , de Boer Renate , Stam Anita G. , van de Ven Rieneke , Levin Mark-David , Pals Steven T. , Roovers Rob C. , Parren Paul W.H.I. , de Gruijl Tanja D. , Kater Arnon P. , van der Vliet Hans J.
Published: April 2023

Supplementary Figures
Supplementary Figures from Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity
Authors: Yang Jinming , Yan Chi , Vilgelm Anna E. , Chen Sheau-Chiann , Ayers Gregory D. , Johnson Christopher A. , Richmond Ann
Published: April 2023

Supplementary Figures 1-6
Figure S6 from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer
Authors: Ji Niannian , Mukherjee Neelam , Shu Zhen-Ju , Reyes Ryan M. , Meeks Joshua J. , McConkey David J. , Gelfond Jonathan A. , Curiel Tyler J. , Svatek Robert S.
Published: April 2023

Figure S6 - Figure.S6 shows combination of rapamycin and BCG increase percentage of effector memory γδ T cells and production of cytokine such as IFNγ within γδ T cells.
Figure S1 from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer
Authors: Ji Niannian , Mukherjee Neelam , Shu Zhen-Ju , Reyes Ryan M. , Meeks Joshua J. , McConkey David J. , Gelfond Jonathan A. , Curiel Tyler J. , Svatek Robert S.
Published: April 2023

Figure.S1 shows that irradiated bladder tumor cells can stimulate in vitro proliferation and cytokine production in autologous peripheral T cells from patients.
Supplementary Figure Legends from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Authors: Diamond Mark S. , Lin Jeffrey H. , Vonderheide Robert H.
Published: April 2023

Supplemental Figure Legends
Supplementary Figure 2 from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Authors: Diamond Mark S. , Lin Jeffrey H. , Vonderheide Robert H.
Published: April 2023

Supplementary Figure 2
Supplementary Figure 1 from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Authors: Diamond Mark S. , Lin Jeffrey H. , Vonderheide Robert H.
Published: April 2023

Supplementary Figure 1